CVRx Announces Availability of Additional Data Supporting Long-term Benefits of Barostim
DAIC
APRIL 16, 2024
a commercial-stage medical device company, announced today the availability of additional data, including the publication of results of the post-market phase of the BeAT-HF trial in the European Journal of Heart Failure. The manuscript is available online at the European Journal of Heart Failure website.
Let's personalize your content